In past days, Troglitazone or Rezulin was available for treating diabetes. It was the anti-inflammatory medication and it was sold in America. This medication was developed by a well known drug manufacturing company named Daiichi Sankyo Co in Japan. Later researchers and experts came to know that this medication could gear up the possibility of the occurrence of the hepatitis. After such official declaration by the scientists, UK banned the drug in 1997.
America withdrew this medication from its market in 2000 and lastly Japan removed this medicine from its market. This medication should not be applicable to those patients whose ALT exceeds 1.5 times. In addition, in case the patient has already been affected by any liver related disease, he should not be given the medication as it will damage the liver. Simultaneously, if the patient consumes liquor or wine, he must not use this medication. The experts opine that doctors should watch the patients in a perfect way whether they experience symptoms like weakness, feeling of squeamish, jaundice and discharging dark colored urine after being offered this medication. If patients suffer a lot from these physical disorders, they must not be treated with this medication under any circumstanceIn this connection, a $60 million worth settlement case has been registered under the Illinois class action lawsuit due to the violation of the contract on the part of the Rezulin manufacturing company. The lawsuit was filed in 2002 against the company as this medication produced the side effects like liver damage.
Therefore people can take the chance of using the legal weaponry to sue the company for the damages and physical disorder which are caused by consuming this medication. A successful and competent lawyer will be much helpful to bring the justice to victims who have suffered unlimited loss due to the intake of Rezulin. Dr. David J. Graham who is recognized to be the eminent analyst and expert of FDA has warned against the side effects of Rezulin. According to his report, this medication is accountable for the lever damage. At least 430 patients who have consumed this medication suffered a lot. Few died of lever damage and few underwent for painful organ replacement. Therefore Warner-Lambert, the former company was charged and blamed for production of defective medication which had already claimed a number of lives and heavy physical wounds/injuries. The present drug manufacturing company, Pfizer Inc. is now facing legal battle in the court because of the ill effect of Rezulin which has caused damage to patients to a great extent.
In October of 1997, there were reports of serious Rezulin side
effects, including 35 cases of liver damage related to Rezulin, two
ending in death. These findings led Warner-Lambert to
recommend that physicians monitor their patients' liver condition by
testing enzyme levels five times during the first year. When this
failed to prevent Rezulin-related liver damage, Warner-Lambert
raised the warning to ten exams for the first year.
On May 19, 2000, the FDA finally requested the withdrawal of
Rezulin. At that time, Rezulin was associated with 90 confirmed
reports of liver failure and 63 deaths. Many people who took Rezulin
have suffered severe liver damage resulting in death or the need
for a liver transplant. It is feared that hundreds more have
sustained permanent liver damage from Rezulin use without even
knowing it.
